Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Revenue Recognition - Disaggregation of Revenue (Details)

v3.21.2
Revenue Recognition - Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]        
Total revenue $ 121,340 $ 125,444 $ 358,597 $ 318,451
Clinical Services        
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]        
Total revenue 102,227 108,733 300,119 275,599
Clinical Services | Client direct billing        
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]        
Total revenue 64,195 72,896 188,040 172,431
Clinical Services | Commercial Insurance        
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]        
Total revenue 19,539 19,218 58,642 56,360
Clinical Services | Medicare and Medicaid        
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]        
Total revenue 18,295 16,460 52,929 46,484
Clinical Services | Self-Pay        
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]        
Total revenue 198 159 508 324
Pharma Services        
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]        
Total revenue $ 19,113 $ 16,711 $ 58,478 $ 42,852